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Abstract
Background:  Few studies have tried to assess the combined cross-sectional and temporal
contributions of a more comprehensive set of amenable factors to population health outcomes for
wealthy countries during the last 30 years of the 20th century. We assessed the overall ecological
associations between mortality and factors amenable to public health. These amenable factors
included addictive and nutritional lifestyle, air quality, public health spending, healthcare coverage,
and immunizations.
Methods: We used a pooled cross-sectional, time series analysis with corrected fixed effects
regression models in an ecological design involving eighteen member countries of the Organisation
for Economic Cooperation and Development during the period 1970 to 1999.
Results: Alcohol, tobacco, and fat consumption, and sometimes, air pollution were significantly
associated with higher all-cause mortality and premature death. Immunizations, health care
coverage, fruit/vegetable and protein consumption, and collective health expenditure had negative
effects on mortality and premature death, even after controlling for the elderly, density of
practicing physicians, doctor visits and per capita GDP. However, tobacco, air pollution, and fruit/
vegetable intake were sometimes sensitive to adjustments.
Conclusion: Mortality and premature deaths could be improved by focusing on factors that are
amenable to public health policies. Tackling these issues should be reflected in the ongoing
assessments of health system performance.
Background
Western populations currently enjoy unprecedented
wealth and longevity [1]. It is held that medical care – or
more broadly healthcare including public health –
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contributed immensely to the increased longevity. How-
ever, McKeown [2], McKinlay et al [3,4], Illich [5] and oth-
ers have questioned the role of medical care in these gains.
Others, like Mackenbach [6,7] and Bunker et al [8,9] con-
tend that medical care has contributed reasonably to the
mortality decline. Unfortunately, these debates have done
little to further the course and relevance of health systems
today. Resource constraints, poor quality, and the contro-
versial World Health Report 2000 [10] have all led to the
increased assessment of health systems in terms of effec-
tiveness [11], safety [12], equity and responsiveness [10].
Meanwhile, the functioning of the public health aspect of
health systems has received less attention. Functional
public health systems are nowadays seen within the con-
text of health promotion and integral social structures
[13]. This focus on health promotion strategies that are
embedded in societal structures has been described as
public health coming "full circle" in the "new public
health" era [14].
The new public health hopes to address major risk factors
implicated in the global burden of disease. These factors,
which threaten the substantial health gains made in the
20th century, include addictive behavior (such as tobacco
smoking), nutritional lifestyle (e.g. fat consumption),
degrading environmental quality (e.g. air pollution), and
less-than-adequate public health investments, coverage
and preventive interventions (e.g. immunizations) [15].
Despite the recent increase in studies that either looked
primarily at such factors or controlled for them in their
analyses [16-22], few studies have tried to assess the com-
bined cross-sectional and temporal contributions of a
more comprehensive set of amenable factors to popula-
tion health outcomes for wealthy countries during the last
30 years of the 20th century.
Therefore, this study uses a pooled, cross-country time-
series design to assess the ecological relationships of such
amenable factors to population health, adjusting for
demographic, national wealth, and medical care-related
factors in selected industrialized countries during the
period 1970–1999. Population health is a commonly
used compound indicator of health system and social per-
formance, and is captured in this study as all-cause mor-
tality and all-cause potential years of life lost. We aim to
speak to the relevance of public health-related issues, and
their place in assessing health system performance.
Theoretical framework
Public Health, as an organized effort of society [23],
espouses several principles, namely: (a) emphasis on col-
lective responsibility and role of the state; (b) focus on
whole populations; (c) emphasis on prevention; (d) con-
cern for the underlying socio-economic determinants of
health and disease; (e) multi-disciplinary approach (both
quantitatively and qualitatively); and (f) partnerships
with populations served [24]. These principles form a use-
ful basis for evaluating the functioning of public health
systems [25]. Simply put, medical care (with its emphasis
on personal clinical services) and public health (with its
emphasis on collective societal efforts for population
health) represent the two traditional components of a
health system [26].
Given public health's broad focus on population health,
the theoretical framework for this study is based on a pop-
ulation health determinants model [27-31]. There are
many determinants of population health which are com-
monly classified as either proximal or distal [18]. The
proximal determinants have direct effects on health, and
the distal determinants have indirect effects.
The proximal determinants, which act on both micro and
macro levels, often include lifestyle or behavior (e.g. alco-
hol, fat, tobacco, fruit and vegetable consumption), and
socioeconomic environment (including macro-economic
measures such as wealth), demography (e.g. elderly pro-
portion of the total population), physical environment
(e.g. air pollution by oxides of sulphur, nitrogen or car-
bon) and host constitution. The health system, which also
operates at this proximal level, shares an interface with
other sectors of organized societies such as the social,
political and economic systems. Health system inputs
such as physicians and medical technology may be the
result of intersectoral dynamics and social choices [32]. It
is expected that public health systems can influence many
of the proximal non-medical determinants and avert or
minimize the need for expensive medical care.
Distal determinants of health include the national, insti-
tutional, political, legal, and cultural factors that indi-
rectly influence health by acting on the more proximal
factors, their interrelated mechanisms, levels, trends, and
distributions. These distal factors are usually more stable
than proximal determinants. Though we do not address
distal factors in this study, we can roughly capture their
potential impact on mortality over time by using dummy
variables to account for any unmeasured time-dependent
heterogeneity introduced by these distal determinants.
Methods
We use an ecological design – a pooled cross-sectional,
time series analysis of secondary data [33,34] – to quan-
tify the relationship between average population health
and factors amenable to public health, taking into
account demographic, medical, and macro-economic
(that is, crude national wealth) determinants of health.
The analysis is based on the country-year units of selected
eighteen member countries of the Organisation ofBMC Public Health 2005, 5:81 http://www.biomedcentral.com/1471-2458/5/81
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Economic Cooperation and Development (OECD) from
1970 to 1999.
Data and measures
The data for this study are derived from secondary sources
[35,36]. The eighteen countries are a convenient sample
of wealthy societies whose health experiences are different
enough to allow for variation, but similar enough to sup-
port effective pooling. These countries, which were used
in a recent study on primary care and mortality, are Aus-
tralia, Belgium, Canada, Denmark, Finland, France, Ger-
many, Greece, Italy, Japan, the Netherlands, Norway,
Portugal, Spain, Sweden, Switzerland, the United King-
dom, and the United States [18]. The data management
and preparation follow the methods used in that study
[18].
The outcome measures of health system performance
used are age- and sex-standardized all-cause total mortality,
and potential years of life lost (PYLL) from all-causes. Both
types of measures, expressed per 100,000 population, are
standardized to the 1980 OECD population. The all-cause
PYLL is a measure of premature, but preventable death
before age 70 years. PYLL is calculated by summing up
deaths occurring at each age and multiplying this with the
number of remaining years to live up to the selected 70-
year limit. Both all-cause mortality and PYLL have been
used in ecological studies of health outcomes [18,37,38].
The independent measures represent four convenient
blocks of amenable factors: addictive behavior/lifestyle;
nutritional lifestyle; environment, investment and cover-
age; and disease preventive measures. Alcohol (measured
in liters per capita) and tobacco (in grams per capita) con-
sumption represent the commoner addictive lifestyle fac-
tors used in studies [18]. Consumptions of fat,  fruit/
vegetable  (both in kilograms per capita), and protein
(measured in grams per capita per day) reflect nutritional
lifestyle. The OECD data on nutritional factors come from
the FAOSTAT database of the Food and Agriculture
Organization of the United Nations [39].
Air pollution is measured as the emission of nitrogen oxide
in kilograms per capita, and is expected to have negative
effects on health and the environment [40]. Collective
(public) health expenditure is a measure of national expend-
iture on prevention, public health services and health
administration (excluding medical or personal care
expenditure), and is hypothesized to have a negative effect
on mortality. We quantified collective expenditure as a
percentage of GDP to reduce collinearity. Although
already at high levels in the selected OECD countries,
healthcare coverage is a good structural variable for the per-
centage of the total population that can access public
healthcare goods and services included in total public
health expenditure, independent of the scope of cost shar-
ing. Here, air pollution, collective health expenditure, and
healthcare coverage represent the environment, public
health investment and coverage.
Percentages of children reaching their first birthday who
were immunized against measles and DTP (diphtheria, tet-
anus and pertussis) are used as measures of preventive
functions of public health, though they could also serve as
outcomes. However, we used two dummy variables to
control for 1980s and 1990s fixed effects, and omitted
variable bias and to eliminate any unobserved heteroge-
neity [34]. The 1970s served as reference.
To account for demographic, medical care, and macro-
economic factors, we chose several well-documented
measures. These were: percentage of the total population
aged 65 year and above as a demographic measure (eld-
erly); practicing physician density per 1,000 population and
per capita doctor visits as measures of medical care input;
and population standardized gross domestic product
(GDP per capita) as a measure of national wealth and a
proxy for medical expenditures [18]. We deflated the GDP
per capita by using the constant 1995 US dollar.
Design and analysis
We employed a pooled cross-sectional time series design
that entailed stacking the eighteen countries (also referred
to as cross-sections) over time. This resulted in a combina-
tion of cross-sections and time series with a matrix config-
uration that considered variation between cross-sections
before variation within cross-sections over time. The obvi-
ous advantage of using a pooled ecological design is that
it increases statistical power. We used fixed effects regres-
sion models and robust statistical modeling techniques to
overcome repeated measure biases, correlated errors and
heterogeneity [41-44]. The final regression model is spec-
ified as follows:
Ynt = γt + β0 + βkXknt + εnt
where
n = 1....18 countries
t = 1....T time points (calendar years from 1970 through
1999)
k = 1....K number of independent variables
γt = set of time effect dummy variable(s)
β0 = constantBMC Public Health 2005, 5:81 http://www.biomedcentral.com/1471-2458/5/81
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βk = pooled regression estimates of the effect of each inde-
pendent variable
Xknt = independent variables per country for each unit year
Unfortunately, simply because the above regression equa-
tion includes both stochastic and non-stochastic varia-
bles, the expected value of the error term is not zero and
the variance is not constant. By assuming all the coeffi-
cients (the βk's) to be the same for each cross-section
within the regression model, we compound the problems
of heteroscedasticity (that is, non-constant variances) or
autoregression (that is, decaying variance due to corre-
lated error terms over time). Autoregression can only be
addressed after heteroscedasticity has been corrected for,
since both anomalies cannot be visualized at the same
time [33]. For pooled data with correlated errors, the ordi-
nary least squares (OLS) method does not yield the correct
standard errors on which to base the hypothesis or rela-
tionship testing under study. To correct for heteroscedas-
ticity in this sample, we employ heteroscedasticity-
consistent standard error (HCSE) estimators which use
the square of the residuals from the OLS equation to
approximate the variance-covariance structure of the
regression estimates [41-44]. Since most of these estima-
tors have not been fully implemented in routine statistical
software packages, we use a special HCSE macro to model
the heteroscedasticity-consistent covariance matrix [44].
Autoregression is then addressed via a quasi-differencing
technique [34].
Alternatively, the pooled cross-sectional time series data
could be treated as repeated observations on each cross-
section, although strictly speaking, here, they represent
average national characteristics per unit time [34]. Similar
results are obtained for this study by using the Linear
Mixed Models procedure of SPSS (version 12.0.2, SPSS
Inc., IL, March 2004) and the SAS PROC MIXED (version
8.2, SAS Institute Inc, NC, 2001) procedure to model the
means, variances and covariances of this data as repeated
measures. However, these general softwares implement a
heteroskedastic-consistent matrix method which uses
conditional variance of the error, rather than the more
robust methods which we used to adjust each squared
residual by a function of how deviant the pattern of inde-
pendent variables of each cross-section is [43].
We used five pre-specified nested models to address the
question 'after adjusting for demographic, medical care
input, and wealth, can mortality and premature death be
still explained by factors amenable to public health?' The
first four models used measures of addictive behavior/life-
style; nutritional lifestyle; environment, investment and
coverage; and preventive measures. Model 1 examined the
effects of tobacco and alcohol on mortality. Model 2
extended model 1 to include fat, fruit/vegetable and pro-
tein consumption. Model 3 added air pollution, collective
health expenditure, and health care coverage. In model 4,
we included measles and DTP immunizations. Finally,
model 5 further adjusted for time fixed effects using per
decade time dummies with the first decade (1970s) as ref-
erence [34]. We also re-estimated models 3 to 5 after
excluding the United States from the healthcare coverage
variable, given the known lower levels of healthcare cov-
erage in the American population. In addition, we re-ran
these models excluding the healthcare coverage variable
entirely in order to gauge its impact on the models consid-
ering that healthcare coverage also reflects access to care in
general, not just public health services. We present statis-
tics for hypothesis testing, model improvement and the
proportion of total variance (as adjusted R squared) in
outcomes explained in the final models, along with the
regression estimates and their modeled standard errors.
Results
Between 1970 and 1999, all-cause mortality and PYLL
decreased on the average by approximately 27% and 37%
respectively across the selected countries (Table 1). Pro-
tein and fruit/vegetable consumption increased while
alcohol, tobacco, and fat intake decreased, albeit with
substantial variation across countries. Fat intake actually
increased in Greece, Italy, Japan, Portugal and Spain by
about 0.2 to 2% annually [35]. Immunization levels and
collective health expenditure also increased. The health-
care coverage levels improved by about 2 to 4 percentage
points when the United States was excluded from the
pool. There were also substantial increases in the elderly
population, national wealth, density of practicing physi-
cians, and doctor visits during the 1970–1999 period.
Table 2 details the regression results for all-cause mortal-
ity. Here, tobacco was positively associated with all-cause
mortality in models 1 to 3, but was not significant in mod-
els 4 and 5 that included immunization variables and
time dummies. Alcohol was significantly and positively
associated with mortality in all the models, yielding mor-
tality increases of 6.6 to 8.6 per 100,000 populations for
every one-liter increase in per capita alcohol consump-
tion. Fat consumption also showed a strong positive rela-
tionship to mortality in all cases. Fruit/vegetable
consumption was only negatively related to mortality in
the full model and when the model excluded environ-
mental, collective health spending, coverage and immuni-
zations. Protein showed a stable negative association in
all models, changing only slightly in model 3. Air pollu-
tion was hardly related to mortality in all models that
included healthcare coverage. Collective health expendi-
ture, healthcare coverage, and immunizations were all
negatively associated with higher mortality (P < 0.01).BMC Public Health 2005, 5:81 http://www.biomedcentral.com/1471-2458/5/81
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Exclusion of the United States data on healthcare coverage
did not substantially alter the models, nor did change its
association with mortality. Although the total exclusion of
the healthcare coverage variable did not improve the fit of
the models (not reported in Table 2), it significantly
changed the mortality associations of tobacco, fruit/vege-
table consumption, and air pollution. Regression coeffi-
cients for tobacco changed from 0.02 to 0.06 (P < 0.001)
and 0.01 to 0.02 (P < 0.0) in only models 3 and 4 respec-
tively. For fruit/vegetable consumption, the estimates
changed from -0.03 to -0.37 (P < 0.001) and -0.10 to -0.25
(P < 0.01) in only models 3 and 4 respectively. For air pol-
lution, the estimates changed from 0.13 to 1.40 (P  <
0.001), 0.46 to 0.79 (P < 0.01) and 0.48 to 0.74 (P < 0.01)
in models 3, 4 and 5 respectively. GDP per capita
remained strongly negatively associated with mortality in
all models. Except for the elderly proportion, all medical
input adjustment covariates were significantly associated
with lower mortality. The total explained variance in all-
cause mortality ranged from 57% in model 1 to 74% in
the fully adjusted model 5.
Table 3 summarizes the corrected fixed effects regression
results for age- and sex-standardized all-cause PYLL, a
measure of premature death. Five stepwise contempora-
neous adjusted models are presented, with each model
compared to the preceding one and model 1 for improve-
ments. Again, tobacco was significantly associated with
higher PYLL in all models except those corrected for
immunization and time effects. Alcohol and fat intake
were positively related to higher PYLL. Fruit/vegetable
intake was only negatively associated with PYLL in model
3 which did not correct for immunization and time
effects. Air pollution tended to be significantly and
positively associated with premature death in the fuller
models (P < 0.001). Protein, collective health expendi-
ture, healthcare coverage, and immunizations all strongly
accounted for lower PYLL. As for total all-cause mortality,
excluding the United States data on healthcare coverage
did not substantially alter our estimates for factors associ-
ated with PYLL. A total exclusion of the healthcare cover-
age variable improved the regression coefficients of air
pollution from 2.92 to 20.14 (P < 0.001) in model 3, and
fruit/vegetable consumption from -0.21 to -2.21 (P <
0.05) in model 5 only. For the premature death outcome,
the regression coefficients varied more in strength than
was seen in Table 2 for all-cause mortality. The full, time-
Table 1: Descriptive statistics for variables used in the pooled cross-sectional time series analysis
Variables 1970–79 1980–89 1990–99
Mean Standard deviation Mean Standard deviation Mean Standard deviation
All-cause mortality (both sexes per 
100,000 population)
938.25 113.74 789.11 79.79 687.65 83.87
Potential years of life lost (before age 
70 years per 100,000 population)
7009.15 1449.67 5372.07 891.38 4424.51 798.37
Tobacco (grams per capita) 2,699.88 450.32 2411.38 455.98 2052.00 502.29
Alcohol consumption (liters per 
capita)
11.62 3.52 11.33 2.94 9.98 2.27
Fat consumption (kilograms of butter 
per capita per year)
5.42 3.76 4.90 3.30 3.56 2.42
Fruit & vegetable consumption 
(kilograms per capita per year)
184.69 61.97 200.14 68.71 220.75 71.03
Protein consumption (grams per 
capita per day)
93.48 8.03 98.62 7.81 103.06 7.52
Pollution (Nitrogen oxide emission, 
in kilograms per capita)
41.50 16.29 43.77 20.72 44.71 26.59
Collective health expenditure (% 
GDP)
0.45 0.24 0.50 0.25 0.53 0.32
Healthcare coverage (% population) 
[without USA]
90.49 [92.2] 13.69 [12.10] 94.16 [96.75] 13.40 [7.10] 93.84 [97.86] 17.61 [5.96]
DTP immunization (% children) 86.61 12.38 87.09 10.56 91.09 8.71
Measles immunization (% children) 59.23 9.57 72.67 12.07 86.58 11.19
Elderly (percentage of population 
over 65 years)
11.58 2.09 13.09 1.93 14.73 1.64
Physician density (per 1,000 
population)
1.58 0.32 2.29 0.45 2.87 0.58
Doctor visits (per capita) 4.08 1.19 5.39 2.17 6.2 2.55
GDP per capita (in constant 1995 US 
dollars)
17,750.94 7,029.03 21,543.59 8,110.65 25,783.31 9,306.90BMC Public Health 2005, 5:81 http://www.biomedcentral.com/1471-2458/5/81
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adjusted model accounted for 79% of the total variance in
PYLL in the pooled countries.
Discussion
Our contemporaneous, pooled cross-sectional series anal-
ysis suggests that a number of factors that may be amena-
ble to public health had important associations with
mortality and premature death in the selected OECD
countries during the period 1970 to 1999. Most of these
associations were still significant even after controlling for
demographics, physician density, visits to the doctor, and
GDP per capita. Tobacco, alcohol and fat intake were all
positively associated with overall mortality and premature
death. Protein consumption, collective health expendi-
ture, healthcare coverage, and immunizations exhibited
negative associations with both outcome measures.
Though air pollution did not have significant effects on
overall mortality, it was sometimes related to higher pre-
mature death when other covariates were fully taken into
account. Fruit/vegetable consumption showed weak and
inconsistent negative effects on both outcome measures,
when partially adjusted for other covariates.
Previous studies have showed that some of the factors we
studied were important in explaining mortality in OECD
countries [12,18,20-22,45]. Though tobacco is known to
be strongly related to higher mortality, our results support
other findings that tobacco becomes insignificant in fuller
models, perhaps suggesting that the tobacco consumption
variable is poorly defined in the OECD dataset [18,45]. It
has been suggested that a better definition would be "per-
cent of population that smokes every day," but not the per
capita use of tobacco we analyzed in this study [18]. Inter-
estingly, in unreported lagged analyses, tobacco only
became significant in fully adjusted models with at least 5
year-lags. It is, however, unclear what this might mean or
how to determine what an appropriate lag period would
be for all covariates in the models. We also found that
tobacco was sensitive to adjustments for healthcare
coverage and time effects in the total all-cause mortality
models, suggesting, perhaps, that while tobacco con-
sumption variable was limited to specific populations
within countries, the healthcare coverage variable had a
wider reach across populations, effectively diluting the
statistical effect of tobacco. Similarly, the failure of fruit/
vegetable consumption and air pollution to show the
expected associations [15,16] in the fuller models in this
study may be due to poor definitions and data quality, or
due to their sensitivity to the effect of healthcare coverage
in the models.
In its 2002 World Health Report, the World Health
Organization showed that lifestyle, behavioral, and envi-
ronmental risk factors, such as the ones in this study,
Table 2: Regression estimates from the pooled cross-sectional time series analysis of all-cause mortality per 100,000 population
Variables Model 1 Estimate 
(S.E.)
Model 2 Estimate 
(S.E.)
Model 3 Estimate 
(S.E.)
Model 4 Estimate 
(S.E.)
Model 5 Estimate 
(S.E.)
Constant 949.32*** (45.75) 1,256.36*** (64.55) 1,487.51*** (80.04) 1,548.45*** (91.38) 1,491.87*** (93.78)
Tobacco 0.03*** (0.01) 0.03*** (0.01) 0.02** (0.01) 0.01 (0.01) 0.01 (0.01)
Alcohol 8.59*** (1.49) 8.59*** (1.50) 6.56*** (1.46) 8.03*** (1.46) 8.61*** (1.52)
Fat consumption 9.44*** (1.66) 9.83*** (1.91) 9.83*** (1.91) 8.46*** (1.96)
Fruit/vegetable 
consumption
-0.20* (0.08) -0.03 (0.09) -0.10 (0.09) -0.19* (0.09)
Protein consumption -3.22*** (0.57) -4.25*** (0.70) -3.93*** (0.76) -3.52*** (0.72)
Air Pollution 0.13 (0.20) 0.46 (0.25) P = 0.07 0.48 (0.26) P = 0.06
Collective health 
expenditure
-72.44*** (18.02) -68.98*** (18.08) -48.95* (19.13)
Healthcare coverage -1.89*** (0.30) -1.73*** (0.31) -1.44*** (0.32)
DTP immunization -1.39*** (0.31) -1.39*** (0.31)
Measles immunization -0.88** (0.27) -0.88** (0.27)
Elderly 4.55* (2.26) 1.47 (2.04) 0.60 (2.19) 4.83* (2.19) 4.87* (2.12)
Physician density -103.65*** (6.34) -47.81*** (7.52) -49.04*** (8.07) -20.57* (8.07) -3.92 (8.74)
Doctor visits -15.55*** (1.75) -9.57*** (1.70) -4.90** (1.80) -5.31** (1.71) -3.60* (1.68)
GDP per capita -0.003*** (0.0004) -0.006*** (0.0005) -0.006*** (0.0005) -0.005*** (0.0005) -0.005*** (0.0005)
1980s fixed effects++ -60.78*** (9.93)
1990s fixed effects++ -83.04*** (14.11)
F change - 38.44# 15.03# 26.57# 17.32#
Adjusted R2 0.57 0.66 0.79 0.72 0.74
S.E.: standard error of estimate; *P < 0.05; **P < 0.01; ***P < 0.001; ++decade time effects to eliminate omitted-variable bias due to unobserved 
heterogeneity with reference to 1970s baseline; #significantly better than preceding model and model 1 (P < 0.000); n = 451BMC Public Health 2005, 5:81 http://www.biomedcentral.com/1471-2458/5/81
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accounted for significant proportions of the disease and
mortality burden in most parts of the world including the
affluent countries [15]. As much as 39–40% of the disease
burden and 51–53% of mortality in developed countries
were attributable to 20 selected risk factors such as
tobacco, alcohol, high blood pressure, high body mass
index, high cholesterol and low fruit and vegetable intake
[17]. Our study is the first, however, to report a pooled
time series impact of tobacco, alcohol, fat, fruit/vegetable,
air pollution, collective health expenditure, healthcare
coverage and immunizations on mortality and premature
death, adjusting for demographics, medical care input
and national wealth in the selected OECD countries dur-
ing the last 30 years of the 20th century. It indirectly sup-
ports some of the aforementioned population risks, but
raises questions as to what public health can actually do
to curb the unhealthy associations.
Revisiting the essential functions of public health
[24,46,47] and its classical paradigms of health promo-
tion, health protection and disease prevention [14] may
offer broad insights into holistic approaches for address-
ing the effects of health determinants. For instance, nutri-
tional lifestyle factors are amenable to health promotion
[15]. Air pollution could be addressed under health protec-
tion  activities such as environmental modification and
regulations. Immunizations against infections such as
measles, diphtheria, tetanus and pertussis belong to the
disease  prevention  role of public health. Although, this
study is ecological in nature, uses population average var-
iables [48,49], and recognizes the potential for the ecolog-
ical fallacy [50], it is unlikely that the solutions to the
problems of, say, alcohol, tobacco, and nutritional life-
style would be entirely ecological. Solutions, such as
behavioral modification, targeted at all levels of the soci-
ety, from individuals to groups, would be necessary.
There is evidence that some countries such as the US
[51,52] and the Netherlands [53] have ongoing initiatives
aimed at tackling health determinants in their popula-
tions. It is yet to be seen how successful these programs
would be if specific attention is not given to re-engineer-
ing public health systems. Increasing healthcare coverage
is yet another important way of improving population
health and its distribution. This is particularly important
for the US where coverage is still a big problem.
Furthermore, the functions of health status monitoring,
surveillance, reducing disaster impact, human resource
development and public health regulation require sub-
stantial investment. Public health investment may have
increased relative to GDP in many OECD countries, but
Table 3: Regression estimates from the pooled cross-sectional time series analysis of all-cause potential years of life lost per 100,000 
population
Variables Model 1 Estimate 
(S.E.)
Model 2 Estimate 
(S.E.)
Model 3 Estimate 
(S.E.)
Model 4 Estimate 
(S.E.)
Model 5 Estimate 
(S.E.)
Constant 7,611.05*** (489.65) 9,020.45*** (831.22) 13,168.22***
(1,221.73)
13,906*** (869.99) 13,458.57*** (890.95)
Tobacco 0.27** (0.10) 0.25* (0.10) 0.14* (0.07) 0.01 (0.07) 0.12 (0.07) P = 0.09
Alcohol 122.74*** (17.18) 120.99*** (17.65) 87.09*** (17.94) 104.86*** (13.51) 110.26*** (13.59)
Fat consumption 67.99*** (17.19) 142.39*** (15.96) 102.44*** (15.20) 91.90*** (15.05)
Fruit/vegetable 
consumption
-0.61 (0.85) -3.08** (1.07) -1.09 (0.85) -0.21 (0.84)
Protein consumption -14.97* (6.46) -31.04*** (7.02) -22.59*** (6.62) -19.01** (6.38)
Air Pollution 2.92 (1.8) 7.31*** (2.16) 7.57** (2.30)
Collective health 
expenditure
-1,268.53*** (261.88) -1,180.31*** (162.92) -1,002.32*** (169.98)
Healthcare coverage -36.32*** (5.32) -28.31*** (3.24) -25.37*** (3.30)
DTP immunization -21.97*** (3.79) -26.20*** (3.77)
Measles immunization -21.28*** (2.87) -14.53** (2.92)
Elderly -66.14** (23.54) -103.99*** (20.32) -70.40*** (19.75) -44.80* (18.88) -47.50** (16.73)
Physician density -768.98*** (72.85) -490.75*** (88.92) -507.20*** (87.45) -41.25 (79.42) -193.32* (89.77)
Doctor visits -129.19*** (17.28) -92.20*** (14.28) -10.50 (18.21) -30.13* (14.25) -13.71 (14.28)
GDP per capita -0.035*** (0.005) -0.052*** (0.006) -0.053*** (0.005) -0.039*** (0.005) -0.04*** (0.005)
1980s fixed effects++ -656.13*** (104.82)
1990s fixed effects++ -775.84*** (141.07)
F change - 14.02# 36.97# 71.43# 21.89#
Adjusted R2 0.57 0.60 0.69 0.77 0.79
S.E.: standard error of estimate; * P < 0.05; ** P < 0.01; *** P < 0.001; ++decade time effects to eliminate omitted-variable bias due to unobserved 
heterogeneity with reference to 1970s baseline; #significantly better than preceding model and model 1 (P < 0.000); n = 451BMC Public Health 2005, 5:81 http://www.biomedcentral.com/1471-2458/5/81
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the attained levels and distribution of collective health
expenditure are still inadequate, given the problems of re-
emerging infections, unsolved issues of poverty and ine-
qualities, global terrorism and environmental degrada-
tion [54]. Currently, many OECD countries spend far
more on the curative medical care sector [55,56] than on
prevention and health promotion [35,36]. Unfortunately,
many of the diseases (e.g. coronary heart disease) treated
in their hospitals, for example, tend to arise from such
preventable factors as excessive tobacco, fat and alcohol
use [15-17]. Our study showed that even after adjusting
for medical care input, there were excess mortality and
premature deaths due to preventable factors.
It, therefore, seems prudent to re-focus on public health
functions of health systems for at least four reasons. First,
it averts health problems and minimizes subsequent mor-
bidity and mortality. Second, public health faces a
legitimacy or relevance problem when it does not deal
competently with the conflict between civil liberties and
health promotion [13], as well as with the new 'epidem-
ics' such as obesity [14,57]. Third, the recent attention
given to health system performance should be more com-
prehensive and include the optimal functioning of public
health systems alongside medical care structures
[10,11,30,58]. Fortunately, the US, UK, Netherlands, Aus-
tralia and Canada are among the countries actively pursu-
ing systematic evaluations of their health systems. Fourth,
public policy on health and health-related social issues
needs to become more integrated, and public health offers
an important interface between the traditional health sec-
tor and the social sectors. There is need for integrated,
intersectoral and innovative solutions beyond the prevail-
ing narrow policy approaches [57,59]. In the light of a
similar OECD study that showed that primary care had
strong relationship with health outcomes [18], even after
controlling for similar factors as we studied, it seems that
strengthening primary care and public health may be a
prudent and an effective strategy against unfavorable
health outcomes. Our study further reinforces recent anal-
yses which used the concept of 'avoidable' mortality (that
is, mortality that should not occur in the presence of effec-
tive and timely healthcare) to point out the importance of
appropriate public health policies as an integral part of
evaluating and improving health system performance
[60,61].
Limitations of this study
This study used data that may have comparability and def-
initional deficiencies [20,35,36]. Use of secondary data
from international resources can import the attendant
problems of incomparable definitions and poor data
quality. The OECD Health dataset (from where we took
our public health and medical care related variables) and
the OECD's Annual National Accounts data (that pro-
vided the expenditure variables in our study) are no excep-
tions. There are likely issues of errors of observation and
comparability in this database given the daunting tasks
that underlie such international data collection efforts.
The incomparability issues are even more likely to be
more severe as the dataset tries to include more non-
healthcare accounts measures such as lifestyle factors, as
has been the case in recent years. Yet, one can be too apol-
ogetic about measurement errors in the OECD Health
dataset given its seeming robustness for routine and
political use and for guiding practical decisions so far [62].
Besides, efforts are constantly being made to increase the
value and quality of the data.
The measures we used are, at best, weak proxies for more
robust measures of aggregate lifestyle, environmental
quality and safety, public health investment and medical
care inputs [61,63]. Medical care input data tend to show
mixed results, especially within the context of avoidable
mortality [61,64]. Furthermore, this study does not pro-
vide clear directions as to which policies are best suited for
addressing lifestyle, environment, public health invest-
ments or any of the factors we studied. The pooled nature
of the statistical models limit the potential for generaliza-
bility of our findings to other countries not included in
this study. Moreover, the estimated models used crude
measures, ignored distributional concerns and distal
determinants of health, and did not consider the possible
multilevel and/or lagged nature of the explored
relationships.
Conclusion
We have presented a pooled, cross-sectional time series
analysis of the associations of public health interventions
and investment, the environment, and lifestyle-related
factors with population health in selected industrialized
countries during the period 1970–1999. Given the limita-
tions of the study, we only make broad-brush assessments
of the relevance of these findings. In view of current health
concerns, our findings serve to make a case for a "new
public health" as a cornerstone of health systems. As such,
health policies aimed at preventable factors, namely those
modifiable by public health, should count in the overall
assessment of health systems.
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